Page last updated: 2024-08-16

sb 202190 and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide

sb 202190 has been researched along with seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collier, ME; ElKeeb, AM; Ettelaie, C; Maraveyas, A1

Other Studies

1 other study(ies) available for sb 202190 and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide

ArticleYear
Accumulation of tissue factor in endothelial cells induces cell apoptosis, mediated through p38 and p53 activation.
    Thrombosis and haemostasis, 2015, Volume: 114, Issue:2

    Topics: Amino Acid Substitution; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cardiovascular Diseases; Cell Line, Tumor; Cell-Derived Microparticles; Cells, Cultured; Coronary Vessels; Cyclin D1; Endothelial Cells; Enzyme Activation; Female; Gene Expression Regulation; Genes, Reporter; Humans; Imidazoles; MAP Kinase Signaling System; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Pyridines; Recombinant Fusion Proteins; RNA Interference; RNA, Messenger; RNA, Small Interfering; Thromboplastin; Transfection; Tumor Suppressor Protein p53

2015